The latest health news highlights Britain's stance on the bioethanol industry, Berkshire Hathaway's investment moves, the FTC's probe into Hims & Hers, Scorpion Capital's position on Soleno ...

A draft of the Trump administration’s highly anticipated blueprint on health policy takes a softer approach to regulating companies than many had feared, a relief for industry and setback for ...

In recent years, men’s health has shifted from being a quiet, private matter to an open conversation fueled by technology and ...

More than 10,000 Air Canada flight attendants went on strike after a deadline to reach a deal passed, the union confirmed early Saturday. Canadian Union of Public Employees ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

Investors with substantial losses have the opportunity (until August 25, 2025) to move the court for appointment as Lead Plaintiff. Shareholder rights firm Hagens Berman is investigating the legal ...

Recent health-related developments include Britain's decisions on the bioethanol industry, Berkshire Hathaway's new stake in ...

Novo Nordisk (NVO) announced that the US Food and Drug Administration has approved an additional indication for Wegovy based ...

West Virginia football’s fan day, originally scheduled for Sunday, Aug. 17, has been rescheduled to Friday, Aug. 22, from ...

Bullish flow in Novo Nordisk (NVO), with shares up $1.52, or 2.99%, near $52.48. Options volume roughly in line with average with 102k contracts ...

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...